Skip to main content
OpenTrials
Completed

NCT Number: NCT02067286

Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer

The objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B & RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as compared to an FDA approved NAAT and culture.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Pediatrics-by-the-Sea, Delray Beach, Florida, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients exhibiting 2 or more symptom groups characteristic of influenza and/or RSV at the time of visit or within the past 48 hours:
  • fever of at least 37.8 C (100F)
  • runny or stuffy nose
  • coughing, wheezing or difficulty breathing
  • sore throat, headache, extreme tiredness, or muscle aches
  • infants: decreased activity, irritability, poor feeding
  • Subject who are able to understand and consent to participation; for minors under the age of 18, this includes a parent or legal guardian

Exclusion criteria

  • Patients who are under-going anti-viral medication now or within the last 7 days.
  • Patients who received Nasal Spray Flu Vaccine within the last 6 weeks

Treatment and study plan

Primary outcomes

  1. Evaluate the sensitivity and specificity of the Liat™ Influenza A/B & RSV Assay and the Liat™ Influenza A/B Assay as compared to an FDA-cleared nucleic acid amplification test

    Time frame: 1 day

Secondary outcomes

  1. Evaluate the sensitivity and specificity of the Liat™ Influenza A/B & RSV Assay and the Liat™ Influenza A/B Assay as compared to culture

    Time frame: 1 day

Sponsors and collaborators

Lead sponsor

IQuum, Inc.

Industry

Collaborators

  • Roche Molecular Systems, Inc

Registry information

Official study title

Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Feb 20, 2014
Registry last updated
Aug 31, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.